Shares of BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) shot up 2.2% during mid-day trading on Wednesday . The stock traded as high as $10.8730 and last traded at $10.8730. Approximately 851 shares changed hands during trading, a decline of 68% from the average session volume of 2,663 shares. The stock had previously closed at $10.64.
BioSyent Stock Up 2.2%
The business has a fifty day moving average price of $10.35 and a 200-day moving average price of $10.55.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
See Also
- Five stocks we like better than BioSyent
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
-tbk-logo-1200x675.png){kind=logo}
